Research > ETFs > ETF / ETP Commentary > 

Sell on the Pop Prospects: April 23 Edition

Here is a look at ETFs that currently offer attractive short selling opportunities. The ETFs included in this list are rated as sell candidates for two reasons. First, each of these funds is deemed to be in a downtrend based on the fact that its 50-day moving average is below its 200-day moving average, which are popular indicators for gauging long-term and medium-term trends, respectively. Second, each of these ETFs is also trading above its 20-day moving average, thereby offering a near-term ‘sell on the pop’ opportunity given the longer-term downtrend at hand. Note that this prospects list also features a liquidity screen by excluding ETFs with average trading volumes below the one million shares mark. As always, investors of all experience levels are advised to use stop-loss orders and practice disciplined profit-taking techniques. To get access to all ETF Database premium content, sign up for a free 14-day trial to ETF Database Pro. Only 21 ETFs made it to the list of sell on the pop prospects this month. The U.S. market indices fell last month amid U.S.-China tensions and tariff turmoils. Real Estate Select Sector SPDR Fund (XLRE B+), Schwab U.S. REIT ETF (SCHH A-), and iShares Global REIT ETF (REET A+) topped the sell on the pop list of last month. The real estate sector has got a boost from positive indicators such as slowing home price increases and decreasing mortgage rates. iShares MSCI India ETF (INDA C+) and WisdomTree India Earnings Fund (EPI C+) were sell on the pop contenders on the list last month. The Indian market experienced gains driven by significant open interest accumulation in Nifty put options, net buying activity from Foreign Institutional Investors (FIIs), and a rise in US futures. Other Asian country ETFs like iShares MSCI Japan ETF (EWJ A), iShares MSCI Emerging Markets ex China ETF (EMXC A), and iShares MSCI South Korea ETF (EWY B) also made it to the list. A surprise tariff exemption from President Trump spurred a technology share rebound, driving the US market higher. This, coupled with a rise in US futures, boosted the overall market sentiment. Check out our list of Asia-Pac Equities ETFs here SPDR S&P Metals & Mining ETF (XME A-) also featured on the list. As the trade war intensified, China halted exports of key rare earth minerals and magnets vital for the global automotive, semiconductor, and aerospace sectors, which has made the metals & mining sector dearer. ProShares Bitcoin Strategy ETF (BITO A-) was one of the sell on the pop candidates on market expectations of Bitcoin acting as a hedge against emerging tariff risks. Deglobalization and rising geopolitical tensions should also provide long-term support for a reserve asset like Bitcoin. AdvisorShares Pure US Cannabis ETF (MSOS ) also made it to the list. U.S. cannabis prices are expected to rise as Trump’s sweeping tariffs hit Asian manufacturing, compounding previous duties. To compare this month’s list with the one published on April 2nd, click here. ETFs to Sell on the PopPlease note that this list is updated on a monthly basis. For more ETF analysis, make sure to sign up for our free ETF newsletter. Disclosure: No positions at time of writing.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.